Toggle switch residues control allosteric transitions in bacterial adhesins by participating in a concerted repacking of the protein core.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
04 2021
04 2021
Historique:
received:
22
11
2020
accepted:
02
03
2021
revised:
23
04
2021
pubmed:
8
4
2021
medline:
4
8
2021
entrez:
7
4
2021
Statut:
epublish
Résumé
Critical molecular events that control conformational transitions in most allosteric proteins are ill-defined. The mannose-specific FimH protein of Escherichia coli is a prototypic bacterial adhesin that switches from an 'inactive' low-affinity state (LAS) to an 'active' high-affinity state (HAS) conformation allosterically upon mannose binding and mediates shear-dependent catch bond adhesion. Here we identify a novel type of antibody that acts as a kinetic trap and prevents the transition between conformations in both directions. Disruption of the allosteric transitions significantly slows FimH's ability to associate with mannose and blocks bacterial adhesion under dynamic conditions. FimH residues critical for antibody binding form a compact epitope that is located away from the mannose-binding pocket and is structurally conserved in both states. A larger antibody-FimH contact area is identified by NMR and contains residues Leu-34 and Val-35 that move between core-buried and surface-exposed orientations in opposing directions during the transition. Replacement of Leu-34 with a charged glutamic acid stabilizes FimH in the LAS conformation and replacement of Val-35 with glutamic acid traps FimH in the HAS conformation. The antibody is unable to trap the conformations if Leu-34 and Val-35 are replaced with a less bulky alanine. We propose that these residues act as molecular toggle switches and that the bound antibody imposes a steric block to their reorientation in either direction, thereby restricting concerted repacking of side chains that must occur to enable the conformational transition. Residues homologous to the FimH toggle switches are highly conserved across a diverse family of fimbrial adhesins. Replacement of predicted switch residues reveals that another E. coli adhesin, galactose-specific FmlH, is allosteric and can shift from an inactive to an active state. Our study shows that allosteric transitions in bacterial adhesins depend on toggle switch residues and that an antibody that blocks the switch effectively disables adhesive protein function.
Identifiants
pubmed: 33826682
doi: 10.1371/journal.ppat.1009440
pii: PPATHOGENS-D-20-02513
pmc: PMC8064603
doi:
Substances chimiques
Adhesins, Bacterial
0
Adhesins, Escherichia coli
0
Fimbriae Proteins
147680-16-8
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1009440Subventions
Organisme : NIAID NIH HHS
ID : R01 AI119675
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008268
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI147575
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Methods. 1996 Jun;9(3):508-15
pubmed: 8812706
Curr Opin Struct Biol. 2015 Dec;35:60-7
pubmed: 26407236
J Biol Chem. 2008 Mar 21;283(12):7823-33
pubmed: 18174167
J Med Chem. 2014 Feb 27;57(4):1416-27
pubmed: 24476493
Clin Microbiol Rev. 1991 Jan;4(1):80-128
pubmed: 1672263
J Am Chem Soc. 2019 Jan 16;141(2):936-944
pubmed: 30543411
Nat Struct Mol Biol. 2011 Apr;18(4):437-42
pubmed: 21378967
Infect Immun. 2011 Oct;79(10):3895-904
pubmed: 21768279
J Mol Biol. 2011 Mar 18;407(1):138-48
pubmed: 21238460
ACS Chem Biol. 2013 Jul 19;8(7):1600-10
pubmed: 23651431
Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2256-68
pubmed: 15572779
J Biol Chem. 2000 Dec 8;275(49):38762-7
pubmed: 11034990
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Protein Eng Des Sel. 2017 May 1;30(5):387-394
pubmed: 28201818
PLoS Comput Biol. 2011 Apr;7(4):e1002034
pubmed: 21533070
J Biomol NMR. 1994 Sep;4(5):603-14
pubmed: 22911360
Biochim Biophys Acta. 2012 Mar;1824(3):520-32
pubmed: 22246133
J Biol Chem. 2004 Jun 25;279(26):27466-71
pubmed: 15123676
Cell. 2010 May 14;141(4):645-55
pubmed: 20478255
J Mol Biol. 2001 Jun 15;309(4):961-74
pubmed: 11399072
J Biol Chem. 1997 Jul 11;272(28):17880-6
pubmed: 9211945
J Phys Chem B. 1998 Apr 30;102(18):3586-616
pubmed: 24889800
J Biol Chem. 2007 Aug 10;282(32):23437-46
pubmed: 17567583
J Biomol NMR. 1995 Nov;6(3):277-93
pubmed: 8520220
J Comput Chem. 2009 Jul 30;30(10):1545-614
pubmed: 19444816
J Biol Chem. 2006 Oct 20;281(42):31668-76
pubmed: 16940049
Philos Trans R Soc Lond B Biol Sci. 2012 Apr 19;367(1592):1112-22
pubmed: 22411982
FEMS Immunol Med Microbiol. 1996 Dec 1;16(2):127-39
pubmed: 8988393
Circulation. 2013 Jul 2;128(1):50-9
pubmed: 23720451
PLoS One. 2008 Apr 30;3(4):e2040
pubmed: 18446213
Nature. 2009 Dec 3;462(7273):602-8
pubmed: 19898420
Nat Commun. 2016 Mar 07;7:10738
pubmed: 26948702
Proc Natl Acad Sci U S A. 2018 Mar 20;115(12):E2819-E2828
pubmed: 29507247
Methods Mol Biol. 2018;1785:29-51
pubmed: 29714010
Sci Adv. 2017 Apr 07;3(4):e1600663
pubmed: 28435869
Biochem Soc Trans. 1995 Aug;23(3):395S
pubmed: 8566283
J Exp Med. 2006 Aug 7;203(8):1939-50
pubmed: 16864659
Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2081-5
pubmed: 7892228
Proteins. 2016 Jul;84(7):990-1008
pubmed: 27090060
Mol Microbiol. 2005 Jan;55(2):441-55
pubmed: 15659162
Science. 1999 Aug 13;285(5430):1061-6
pubmed: 10446051
J Biol Chem. 1996 Aug 23;271(34):20365-74
pubmed: 8702772
J Cell Sci. 2009 Nov 15;122(Pt 22):4009-11
pubmed: 19910492
J Mol Biol. 1993 Dec 5;234(3):554-63
pubmed: 7504735
Bioinformatics. 2015 Aug 15;31(16):2751-3
pubmed: 25886981
Nature. 2011 May 18;474(7352):521-5
pubmed: 21593763
Nat Commun. 2015 Jun 15;6:7283
pubmed: 26073186
Mol Immunol. 2012 Jul;51(3-4):304-9
pubmed: 22520973
Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9884-9
pubmed: 26216967
PLoS Pathog. 2015 May 14;11(5):e1004857
pubmed: 25974133
Biophys J. 2006 Feb 1;90(3):753-64
pubmed: 16272438
J Immunol. 2013 Aug 1;191(3):1428-35
pubmed: 23797669
Nature. 2011 Mar 31;471(7340):656-60
pubmed: 21389983
J Biol Chem. 2013 Aug 16;288(33):24128-39
pubmed: 23821547
J Biol Chem. 2011 Feb 4;286(5):3658-70
pubmed: 21098036
Methods. 2013 Mar 15;60(1):3-14
pubmed: 23280336